BiotechTube
Home/ARScience Biotherapeutics/Jorge Zylberberg
JZ

Jorge Zylberberg

Co-founder

ARScience Biotherapeutics

Therapeutic Areas

OncologyAutoimmune Diseases

ARScience Biotherapeutics Pipeline

DrugIndicationPhase
COYA 301 (Low-dose IL-2)Autoimmune/Inflammatory (via Treg expansion)Phase 1

Leadership Team at ARScience Biotherapeutics

CZ
Claudia Zylberberg
Chair and Co-founder
CB
Carlos Banando
CEO
JC
Jorge Cassara
Co-founder
View full ARScience Biotherapeutics profile